Position history for B. Metzler seel. Sohn & Co. AG's holdings in VERTEX PHARMACEUTICALS INC
B. Metzler seel. Sohn & Co. AG holds 515,269 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $233.6M as of 2025-Q4. The position was increased (++63.4% shares). VRTX represents 2.0% of B. Metzler seel. Sohn & Co. AG's portfolio.
Current Value
$233.6M
Current Shares
515,269
Total Value Change
+$217.1M
Total Shares Change
+480,034
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 515,269 |
+63.4% |
| $233.6M |
| 2.0% |
| $453.74 |
77 |
| 2025-Q3 | Decreased | 315,422 | -1.3% | $123.5M | 1.1% | $395.31 | 0 |
| 2025-Q2 | Increased | 319,621 | +1.7% | $142.3M | 1.4% | $441.30 | 48 |
| 2025-Q1 | Increased | 314,343 | +289.2% | $152.4M | 1.6% | $492.69 | 77 |
| 2024-Q4 | Increased | 80,759 | +101.9% | $32.4M | 0.3% | $399.35 | 56 |
| 2024-Q3 | Increased | 39,993 | +13.5% | $18.6M | 0.2% | $462.88 | 38 |
| 2024-Q2 | Increased | 35,235 | +126.8% | $16.5M | 0.2% | $468.72 | 54 |